Scientists identified a new compound called F6 that on preliminary testing is potent against antibiotic-resistant pathogens such as MRSA, VRSA, and vancomycin-resistant Enterococcus (VRE), with vancomycin considered a drug of last resort. Tests indicate it is also less susceptible to resistance.

Scientists identified a new compound called F6 that on preliminary testing is potent against antibiotic-resistant pathogens such as MRSA, VRSA, and vancomycin-resistant Enterococcus (VRE), with vancomycin considered a drug of last resort. Tests indicate it is also less susceptible to resistance.: https://ift.tt/2HVGL4L Read more... https://ift.tt/2JN1sW4